REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Corcept Therapeutics Inc. (CORT) on Tuesday reported third-quarter net income of $19.4 million.
On a per-share basis, the Redwood City, California-based company said it had profit of 16 cents.
The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 18 cents per share.
The drug developer posted revenue of $207.6 million in the period, also falling short of Street forecasts. Four analysts surveyed by Zacks expected $219.2 million.
Corcept expects full-year revenue in the range of $800 million to $850 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CORT at https://www.zacks.com/ap/CORT
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
